IL6 and systemic sclerosis: Moreover, the receptor IL-1R is overexpressed by SSc fibroblasts, and inhibition of IL-1R leads to the decreased release of IL-6 and PDGF-A in those fibroblasts, consistent with a paracrine pathway between keratinocytes and dermal fibroblasts [52].